Compare Cipta Sarana Medika Tbk. (DKHH) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp65 (market cap 160.67B, 20M 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 170.67B, 1.08M 24h volume). The key difference: Cipta Sarana Medika Tbk. and Zyrexindo Mandiri Buana Tbk. are close in size by market cap, and Cipta Sarana Medika Tbk. is more actively traded (20M versus 1.08M). Which is the better fit depends on your goals.
| DKHH | ZYRX | |
|---|---|---|
Market Cap | 160.67B | 170.67B |
Volume | 20M | 1.08M |
Lot | 199.96K | 10.83K |
Turnover | 1.31B | 139.68M |
Average Price | 65.32 | 128.99 |
Value | 1.31B | 139.68M |
Indicative Equilibrium Price | 64 | 124 |
Indicative Equilibrium Volume | 1.35K | 51 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Zyrexindo Mandiri Buana Tbk.
PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →
